Nisa Investment Advisors, LLC Rigel Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$1.12 - $1.57 $332 - $466	297 Added 220.0%	432 $0
Q3 2023 Nov 02, 2023	SELL	$1.07 - $1.39 $29 - $38	-28 Reduced 17.18%	135 $0
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.82 $7,168 - $11,648	-6,400 Reduced 97.52%	163 $0
Q1 2023 May 02, 2023	BUY	$1.25 - $2.0 $8,000 - $12,800	6,400 Added 3926.38%	6,563 $9,000
Q4 2022 Feb 02, 2023	BUY	$0.67 - $11.9 $109 - $1,939	163 New	163 $0

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.